GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
GRI Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.45+0.07 (+5.07%)
Close on Oct 19, 2026
- Market cap
- $2.62M
- P/E (TTM)
- –
- Dividend yield
- –
GRI Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | GRI Bio | Industry median |
|---|---|---|
| Market Cap | $3.17M | $164.85M |
| Enterprise Value | -$7.78M | $87.06M |
| PB Ratio | 0.31 | 2.03 |
| P/TBV Ratio | 0.31 | 2.31 |
Income (trailing twelve months)
| Measure | GRI Bio | Industry median |
|---|---|---|
| Operating Income | -$9.68M | -$21.44M |
| Net Income | -$9.66M | -$22.46M |
| EBITDA | -$9.68M | -$16.91M |
Returns
| Measure | GRI Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -142.0% | -53.1% |
| Return on Assets (ROA) | -113.3% | -41.0% |
| Return on Capital Employed (ROCE) | -94.2% | -37.8% |
Balance sheet
| Measure | GRI Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $10.95M | $62.42M |
| Net Cash (Debt) | $10.95M | $15.68M |
| Net Cash Per Share | $5.01 | $0.66 |
| Equity (Book Value) | $10.28M | $48.79M |
| Book Value Per Share | $4.70 | $1.36 |
| Tangible Book Value | $10.28M | $23.06M |
| Working Capital | $10.23M | $75.77M |
Financial position
| Measure | GRI Bio | Industry median |
|---|---|---|
| Current Ratio | 10.30 | 3.30 |
| Quick Ratio | 9.95 | 2.39 |
Cash flow (trailing twelve months)
| Measure | GRI Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$10.42M | -$12.35M |
Efficiency
| Measure | GRI Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$2.41M | -$703.34K |
| Employee Count | 4 | 74 |
Dividends and yields
| Measure | GRI Bio | Industry median |
|---|---|---|
| Earnings Yield | -304.7% | -22.7% |
Shares
| Measure | GRI Bio | Industry median |
|---|---|---|
| Shares Outstanding | 2,186,120 | 58,179,650 |
| Shares Change (QoQ) | 37.9% | 0.54% |
| Float | 1,614,320 | 49,173,100 |
| Shares Held by Insiders | 26.2% | 11.6% |
| Shares Held by Institutions | 4.28% | 59.4% |
Scores
| Measure | GRI Bio | Industry median |
|---|---|---|
| Altman Z-Score | -6.81 | -0.24 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from GRI Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.